Adverse events ‐ migraine · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ migraine compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ depression · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ depression compared with placebo (very low certainty).
1 finding from 1 review
Biopsy‐proven recurrence of endometriosis · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes biopsy‐proven recurrence of endometriosis compared with placebo (very low certainty).
1 finding from 1 review
Participant perception of change with treatment · adult men with premature ejaculation
SSRI probably leads to higher participant perception of change with treatment compared with placebo (moderate certainty).
1 finding from 1 review
Participant satisfaction with intercourse · adult men with premature ejaculation
SSRI probably leads to higher participant satisfaction with intercourse compared with placebo (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · adult men with premature ejaculation
SSRI may leads to higher study withdrawal due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Perceived control over ejaculation · adult men with premature ejaculation
SSRI probably leads to higher perceived control over ejaculation compared with placebo (moderate certainty).
1 finding from 1 review
Participant distress about PE · adult men with premature ejaculation
SSRI probably leads to higher participant distress about PE compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events · adult men with premature ejaculation
SSRI probably leads to higher adverse events compared with placebo (moderate certainty).
1 finding from 1 review
IELT · adult men with premature ejaculation
1 finding from 1 review
Mental state: significant response or improvement in negative symptoms (PANSS negative subscale, high = worse) ‐ short term (12 weeks) · adults with schizophrenia
It is very uncertain whether noradrenaline reuptake inhibitors changes mental state: significant response or improvement in negative… compared with placebo (very low certainty).
1 finding from 1 review
Mental state: 2. Positive symptoms ‐ average endpoint score PANSS positive subscore · adults with schizophrenia
1 finding from 1 review
Clinical global response: significant response or improvement in global status (CGI‐S, high = worse) ‐ short term (4 weeks) · adults with schizophrenia
It is very uncertain whether noradrenaline reuptake inhibitors changes clinical global response: significant response or improvement in… compared with placebo (very low certainty).
1 finding from 1 review
Cognitive functioning: significant response or improvement in cognitive functioning · adults with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive function: average endpoint score** · adults with schizophrenia
1 finding from 1 review
QoL · adults with schizophrenia
1 finding from 1 review
Nausea · adults with schizophrenia
Noradrenaline reuptake inhibitors showed no clear difference in adverse effects: Nausea ‐ short term (2 to 12 weeks) compared with placebo (low certainty).
1 finding from 1 review
Quality of life: change in symptom severity score · women with uterine fibroids
1 finding from 1 review
Abnormal uterine bleeding: amenorrhoea · uterine fibroids
SPRM showed no clear difference in abnormal uterine bleeding: amenorrhoea compared with leuprolide acetate (moderate certainty).
1 finding from 1 review
Pelvic pain · uterine fibroids
1 finding from 1 review